CVS Current Assets vs Debt Non Current Analysis
CVS Stock | USD 55.82 0.14 0.25% |
Trend analysis of CVS Health Corp balance sheet accounts such as Short Long Term Debt Total of 83.4 B, Other Current Liabilities of 2.3 B or Total Current Liabilities of 83.1 B provides information on CVS Health's total assets, liabilities, and equity, which is the actual value of CVS Health Corp to its prevalent stockholders. By breaking down trends over time using CVS Health balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
CVS |
About CVS Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of CVS Health Corp at a specified time, usually calculated after every quarter, six months, or one year. CVS Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CVS Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CVS currently owns. An asset can also be divided into two categories, current and non-current.
CVS Health Balance Sheet Chart
CVS Health Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how CVS Health Corp uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, CVS Health's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 3.8 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 984.2 M in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of CVS Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CVS Health Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on CVS Health balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CVS Health Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from CVS Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CVS Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, CVS Health's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.21 in 2024, whereas Tax Provision is likely to drop slightly above 2 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Operating Income | 13.2B | 16.3B | 13.7B | 14.4B | Other Operating Expenses | 277.1B | 306.4B | 601.0B | 631.0B |
CVS Health fundamental ratios Correlations
Click cells to compare fundamentals
CVS Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CVS Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Short Long Term Debt Total | 89.0B | 85.0B | 76.0B | 70.7B | 79.4B | 83.4B | |
Other Current Liab | 4.8B | 5.8B | 5.6B | 47.6B | 2.5B | 2.3B | |
Total Current Liabilities | 53.3B | 62.0B | 67.8B | 69.7B | 79.2B | 83.1B | |
Total Stockholder Equity | 63.9B | 69.4B | 75.1B | 71.0B | 76.5B | 80.3B | |
Property Plant And Equipment Net | 32.9B | 33.3B | 32.0B | 30.7B | 30.4B | 32.0B | |
Net Debt | 83.3B | 77.2B | 66.6B | 57.8B | 71.2B | 74.7B | |
Retained Earnings | 45.1B | 49.6B | 54.9B | 56.1B | 61.6B | 64.7B | |
Cash | 5.7B | 7.9B | 9.4B | 12.9B | 8.2B | 8.6B | |
Non Current Assets Total | 172.1B | 174.3B | 173.0B | 162.6B | 181.9B | 191.0B | |
Non Currrent Assets Other | 4.6B | 4.6B | 4.7B | 4.0B | 3.6B | 3.8B | |
Cash And Short Term Investments | 8.1B | 10.9B | 12.5B | 15.7B | 11.5B | 12.0B | |
Net Receivables | 19.6B | 21.7B | 24.4B | 27.3B | 35.2B | 37.0B | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 984.2M | |
Liabilities And Stockholders Equity | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Non Current Liabilities Total | 105.0B | 99.0B | 89.8B | 87.2B | 93.9B | 98.6B | |
Inventory | 17.5B | 18.5B | 17.8B | 19.1B | 18.0B | 18.9B | |
Other Current Assets | 5.1B | 5.3B | 5.3B | 2.7B | 3.2B | 3.3B | |
Other Stockholder Equity | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (33.8B) | (32.1B) | |
Total Liab | 158.3B | 161.0B | 157.6B | 157.0B | 173.1B | 181.7B | |
Property Plant And Equipment Gross | 32.9B | 33.3B | 12.9B | 12.9B | 51.1B | 53.7B | |
Total Current Assets | 50.3B | 56.4B | 60.0B | 65.7B | 67.9B | 71.3B | |
Accumulated Other Comprehensive Income | 1.0B | 1.4B | 965M | (1.5B) | (297M) | (311.9M) | |
Short Term Debt | 5.4B | 7.1B | 5.9B | 3.5B | 4.7B | 4.9B | |
Intangible Assets | 33.1B | 31.1B | 29.0B | 24.8B | 29.2B | 30.7B | |
Accounts Payable | 10.5B | 11.1B | 12.5B | 14.8B | 14.9B | 15.6B | |
Common Stock | 46.0B | 46.5B | 47.4B | 48.2B | 49.0B | 51.4B | |
Good Will | 79.7B | 79.6B | 79.1B | 78.2B | 91.3B | 95.8B | |
Common Stock Total Equity | 46.0B | 46.5B | 47.4B | 48.2B | 55.4B | 58.2B | |
Other Liab | 21.4B | 21.0B | 19.7B | 19.9B | 22.9B | 24.1B | |
Other Assets | 9.1B | 51.0B | 9.8B | 7.6B | 8.7B | 4.8B | |
Long Term Debt | 64.7B | 59.2B | 52.0B | 50.5B | 58.6B | 61.6B | |
Treasury Stock | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (28.7B) | (27.2B) | |
Property Plant Equipment | 32.9B | 12.6B | 12.9B | 12.9B | 14.8B | 9.5B | |
Current Deferred Revenue | 32.6B | 38.0B | 43.8B | 3.9B | 57.1B | 60.0B | |
Short Term Investments | 2.4B | 3B | 3.1B | 2.8B | 3.3B | 3.4B | |
Net Tangible Assets | (49.0B) | (41.3B) | (33.1B) | 71.0B | 63.9B | 67.1B | |
Noncontrolling Interest In Consolidated Entity | 318M | 306M | 312M | 300M | 345M | 362.3M | |
Retained Earnings Total Equity | 45.1B | 49.6B | 54.9B | 56.1B | 64.6B | 39.9B | |
Long Term Debt Total | 64.7B | 59.2B | 52.0B | 50.5B | 58.0B | 34.0B |
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving together with CVS Stock
0.73 | AGCB | Altimeter Growth 2 | PairCorr |
Moving against CVS Stock
0.74 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
0.64 | MMM | 3M Company Financial Report 23rd of July 2024 | PairCorr |
0.62 | GOOD | Gladstone Commercial | PairCorr |
0.61 | CVX | Chevron Corp Financial Report 26th of July 2024 | PairCorr |
0.55 | PG | Procter Gamble Financial Report 26th of July 2024 | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.47) | Dividend Share 2.48 | Earnings Share 5.7 | Revenue Per Share 281.151 | Quarterly Revenue Growth 0.036 |
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.